OR WAIT null SECS
August 24, 2018
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Dompé Farmaceutici’s Oxervate (cenegermin), a topical eye drop, is the first treatment approved by the agency for neurotrophic keratitis, a rare disease affecting the cornea.
August 17, 2018
The company’s purpose-built facility in Norwich, United Kingdom specializes in plant-based expression of proteins, metabolites, and complex natural products.
August 16, 2018
FDA grants support US research in continuous manufacturing monitoring and control techniques for bio/pharmaceutical manufacturing at Rutgers, MIT, and Georgia Tech.
August 14, 2018
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
August 13, 2018
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
August 08, 2018
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
August 06, 2018
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
August 02, 2018
The company broke ground on its $200-million, 120,000-ft2 biomanufacturing plant in West Greenwich, RI.